The Predictive Value of Three Variables in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-Based Combination Therapies in Randomized Clinical Trials: A Systematic Review and Meta-Analysis.

J Oncol · 2022 · PMC9482552 · PMID 36124031

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an overall trendno p-value reported

Compared with sunitinib, our meta-analysis suggested an overall trend for immune-based combination therapies providing preferable OS and PFS benefits in mRCC patients, regardless of age and gender.

also in 4,871 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.